12th EGA International Biosimilar Medicines Conference

January 17, 2014 2:01 PM

European Generics Association’s 12th International Biosimilar Medicines Conference will be held in London, UK between 3-4 April 2014.

EGA Symposium Highlights 2014:

  • Current status and future outlook of the biosimilar medicines market
  • Biosimilars business opportunities beyond the EU and the USA
  • Next steps of the “Tajani initiative” and the European Commission industrial policy strategy
  • Update on biosimilars utilisation and best practices around Europe supporting uptake
  • Outcome of the GfK Bridgehead report on the sustainability of the biosimilars market
  • Most recent developments regarding EMA pioneering guidelines
  • Progress on global framework for biosimilar development: insight from EMA, FDA and KFDA
  • EU extensive experience with biologics prescribing, naming, traceability and pharmacovigilance
  • Extrapolation of indications: regulators’ experience with assessment of the first biosimilar monoclonal antibody
  • Biosimilarity concept: a paradigm shift for many key stakeholders
  • Biosimilars for doctors: interactive panel session with renowned clinicians and key EU regulators

For full information, the website of the conference is: http://www.gpaconferences.com/bios.htm

Would you like to post an event on Biosimilar News?

Comments are closed

Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?

Suggestions?

Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!